Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool]
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ:AMEX Investor Relations:
ir.inovio.com/investors/default.aspx
Company Research
Source: The Motley Fool
Dow Falls 350 Points as Coronavirus Fears Grow Markets are starting the week off on a worried note, with major exchanges around the world reporting major losses. U.S. stocks saw significant losses on Monday as news of the deadly coronavirus worries investors. The Dow Jones Industrial Average is down 350 points or 1.2% this morning, while the S&P 500 is also down 1.2%. The tech-oriented Nasdaq shed 140 points, down 1.5%. According to Chinese officials, the death toll in China has grown to 81. The National Health Commission stated that over 2,700 people have been diagnosed with the condition, mainly in the Hubei province of China which is now in lockdown. The number of U.S. cases has gone up as well, from just one individual diagnosed with the coronavirus before the weekend to now five people. It's been over three months since the S&P 500 moved up or down over 1% in a single trading day. Stocks have steadily gone up since October when the Trump Administration confirmed that it was close
Show less
Read more
Impact Snapshot
Event Time:
INO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INO alerts
High impacting Inovio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
INO
News
- Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at HC Wainwright from $12.00 to $5.00. They now have a "neutral" rating on the stock.MarketBeat
- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $33.00 to $15.00. They now have an "outperform" rating on the stock.MarketBeat
- Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $7.00 to $6.00. They now have a "sector perform" rating on the stock.MarketBeat
INO
Earnings
- 11/14/24 - Beat
INO
Sec Filings
- 11/14/24 - Form 8-K
- 11/14/24 - Form 10-Q
- 11/8/24 - Form SC
- INO's page on the SEC website